Feist-Weiller Cancer Center News

KEEL Radio News - LSU Health Shreveport starts two promising COVID Clinical Trials - image of scientist in the lab

LSU Health Shreveport / Feist-Weiller Cancer Center is a strategic partner with MD Anderson and the Cancer Focus Fund LP working to advance promising cancer therapies.

Read More about March Biosciences and Cancer Focus Fund Announce $4.8 Million Investment to Support a Phase 2 Clinical Trial of Novel CAR-T Therapy for T-Cell Lymphoma (opens in new window/tab)
Dr. Gary Burton instructs staff at Feist-Weiller Cancer Center

Feist-Weiller Cancer Center, a Center of Excellence in Cancer Research, Treatment and Education at LSUHS and Loxo@Lilly, the oncology unit of Eli Lilly and Company, recently launched a new research collaboration that will provide next-generation sequencing (NGS) access to underserved cancer patients in the northern Louisiana region.

Read More about LSUHS, Loxo@Lilly Partner to Study Impact of Next-Generation Sequencing on Cancer Treatment Decisions and Patient Outcomes